A safety Centralized monitoring of Kanglaite Injection

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022813

Enrollment

Unknown

Registered

2019-04-27

Start date

2019-05-01

Completion date

Unknown

Last updated

2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumour

Interventions

Case series:Kanglaite injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients in the hospital who used Kanglaite injection

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Adverse Event;	—

Countries

China

Contacts

Public ContactJie Li

Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences

drjieli2007@126.com15901270817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026